ALS biorepository

Ended Definitive Contract Awarded Last action

Contract number
75D30120C08465
Awardee
Awarding agency
Obligated
$7,023,932

Award facts

Opportunity
Contract value 87% obligated
  • $7,031,575.41 Current, with exercised options
  • $8,046,975.18 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
621991 Blood and Organ Banks
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
Pricing
Time and Materials
Place of performance
Fairfax, VA 22031, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Exercise an Option P00014 $235,009
Other Administrative Action P00013 $0
Exercise an Option P00012 $1,395,008
Other Administrative Action P00011 -$15
Other Administrative Action P00010 $0
Other Administrative Action P00009 $0
Other Administrative Action P00008 -$7,628
Exercise an Option P00007 $2,442
Exercise an Option P00006 $1,354,254
Supplemental Agreement for work within scope P00005 $4,830
Exercise an Option P00004 $1,297,333
Exercise an Option P00003 $3,814
Exercise an Option P00002 $1,259,780
Supplemental Agreement for work within scope P00001 $0
Original award $1,479,106
Show all 15

About this award

The Centers for Disease Control and Prevention awarded an $8.0 million time and materials contract to Mcking Consulting Corporation on September 23, 2020, to operate and maintain a national biorepository for the National ALS Registry. Under this total small business set-aside contract, Mcking will manage specimen collection, transport, maintenance, cataloging, and logistics for biological samples from over 15,000 amyotrophic lateral sclerosis patients. The biorepository maintains diverse specimen types including blood, urine, saliva, hair, nails, and post-mortem tissues that support ongoing research into ALS causes and treatments. The contract, which is scheduled for completion by March 27, 2026, will be performed at the contractor's facility in Fairfax, Virginia.

Mcking Consulting Corporation brings relevant experience in specialized research support and technical assistance to federal health agencies. The contractor has previously delivered scientific and professional services to the CDC in areas including ALS research, chronic fatigue syndrome support, and epidemiological studies through various contract vehicles. This engagement with the CDC's ALS biorepository aligns with the agency's research mission and supports the National ALS Registry's broader objectives to advance understanding of this neurodegenerative disease through specimen-based research and analysis.

Quick answers

Who was awarded contract 75D30120C08465?

75D30120C08465 was awarded to Mcking Consulting Corporation by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 23, 2020.

How much is contract 75D30120C08465 worth?

The government has obligated $7,023,932 on 75D30120C08465. Its current value, with exercised options, is $7,031,575. Its potential value, with all options, is $8,046,975.

Was contract 75D30120C08465 competed?

The extent of competition for 75D30120C08465 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award